1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Comprehensive Addiction and Recovery Act (CARA) Community-based Coalition Enhancement Grants to Address Local Drug Crises Grants (CARA Local Drug Crises Grants) is sponsored by U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC), and Office of National Drug Control Policy (ONDCP). This program is an enhancement to current or formerly funded Drug-Free Communities (DFC) Support Program recipients.
Get alerted about grants like this
Save a search for “U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC), and Office of National Drug Control Policy (ONDCP)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Comprehensive Addiction and Recovery Act (CARA) Local Drug Crises Grants Comprehensive Addiction and Recovery Act (CARA) Local Drug Crises Grants Agency: Centers for Disease Control - NCIPC Assistance Listings: 93. 799 -- CARA Act – Comprehensive Addiction and Recovery Act of 2016 Last Updated: February 5, 2021 View version history on Grants.
gov The Drug-Free Communities (DFC) Support Program was created by the Drug-Free Communities Act of 1997 (Public Law 105-20).
The Executive Office of the President, Office of National Drug Control Policy (ONDCP), and the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC) are accepting applications for Fiscal Year (FY) 2021 Comprehensive Addiction and Recovery Act (CARA) Community-based Coalition Enhancement Grants to Address Local Drug Crises Grants (CARA Local Drug Crises Grants) as an enhancement...
to current or formerly funded Drug-Free Communities (DFC) Support Program recipients. The purpose of this program is to prevent and reduce the abuse of opioids or methamphetamines and the abuse of prescription drugs among youth ages 12-18 in communities throughout the United States.
Nonprofits non-higher education with 501(c)(3) Eligible applicants are community-based coalitions addressing opioid, methamphetamine, and/or prescription drug use/misuse by local youth.
They must be a nonprofit (as defined by the IRS as a 501(c) organization); or an entity that the Administrator determines to be appropriate; or part of, or is associated with an established legally recognized domestic, public or private nonprofits organization. For example, state and local governments, federally recognized tribes, state-recognized tribes, urban Indian organizations (as defined in Pub. L.
No. 94-437), public or private universities and colleges, professional associations, voluntary organizations, self-help groups, consumer and provider services-oriented constituency groups, community- and faith-based organizations, and tribal organizations. (Pub. L.
No. 114-198 Sec 103). In addition, applicants must document rates of misuse of opioids or use of methamphetamines that are higher than the national average over a sustained period. The statutory authority for this program (Section 103 of the Comprehensive Addiction and Recovery Act) limits eligibility to domestic public and private nonprofit entities that are current or former Drug-Free Communities (DFC) Support Program recipients.
The intent of the CARA Support Program is to fund coalition activities in the United States and does not authorize the funding of organizations or activities outside the United States. A CARA legal applicant (an organization applying on behalf of a coalition, the coalition, or the applicant coalition) must reside within the United States and/or the U.S. territories.
Refer to Table 3 Statutory Eligibility Requirements: which contains, the minimum eligibility requirements, the evidence required, and where to document the requirement. The table also specifies which attachment to use to provide the necessary evidence to document your compliance with the eligibility requirement.
All CARA applications will be jointly screened by ONDCP and CDC to determine whether an applicant meets all the CARA Support Program Statutory Eligibility Requirements identified in Table 3. Applications submitted by eligible coalitions that demonstrate they meet all requirements will then be scored through a merit review process according to the evaluation criteria described in Section E. Review and Selection Process of this NOFO.
Grantor contact information File name Description Last updated Foa_Content_of_CDC-RFA-CE21-2103_revised020421. pdf Foa_Content_of_CDC-RFA-CE21-2103_revised020421. pdf Feb 5, 2021 01:16 AM UTC Appendix_D-_Attach-ment_5_Coalition_Meeting_Minutes.
docx Appendix D- Attach-ment 5_Coalition Meeting Minutes. docx Feb 1, 2021 07:12 PM UTC Appendix_D-_Attach-ment_2_MOU_. docx Appendix D- Attach-ment 2_MOU_.
docx Feb 1, 2021 07:12 PM UTC Appendix_A_-_Pre-Submission_Verification_Checklist_for_CARA. docx Appendix A: Pre-Submission Verification Checklist Feb 1, 2021 07:04 PM UTC Appendix_D-_Attach-ment_4_Statement_of_Rates. docx Appendix D- Attach-ment 4_Statement of Rates.
docx Feb 1, 2021 07:05 PM UTC Appendix_D-_Attach-ment_3_Disclosure_of_DFC_Support_Program_Funding. docx Appendix D- Attach-ment 3_Disclosure of DFC Support Program Funding. docx Feb 1, 2021 07:12 PM UTC Appendix_D-_Attach-ment_6_Key_Personnel_Resumes.
docx Appendix D- Attach-ment 6_Key Personnel Resumes. docx Feb 1, 2021 07:05 PM UTC Appendix_D-_Attach-ment_7_CARA_Act_Program_Evaluation_Requirements. docx Appendix D- Attach-ment 7_CARA Act Program Evaluation Requirements.
docx Feb 1, 2021 07:12 PM UTC Appendix_B-_Resources_on_Evidence-Based_and_Practice-Based_Strategies_and_Activities. docx Appendix B: Resources on Evidence-Based and Practice-Based Strategies and Activities Feb 1, 2021 07:05 PM UTC Appendix_D-_Attach-ment_1_Assurance_of_Legal_Eligibility. docx Appendix D- Attach-ment 1_Assurance of Legal Eligibility.
docx Feb 1, 2021 07:13 PM UTC Appendix_D-_Attach-ment_8_General_Applicant_Information. docx Appendix D- Attach-ment 8_General Applicant Information. docx Feb 1, 2021 07:11 PM UTC Appendix_C_-_Review_and_Selection_Process.
docx Appendix C: Review and Selection Process Feb 1, 2021 07:11 PM UTC Appendix_D-_Attach-ment_9_Sample_Congressional_Notification. docx Appendix D- Attach-ment 9_Sample Congressional Notification. docx Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity :
Based on current listing details, eligibility includes: Current or formerly funded Drug-Free Communities (DFC) Support Program recipients. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified (enhancement to existing DFC grants) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is April 28, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
AAI Career Awards is a grant from the American Association of Immunologists (AAI) that honors members for outstanding research and career achievement. Through multiple award tracks — including the Lifetime Achievement Award, Distinguished Service Award, Distinguished Fellows program, Public Service Award, and Vanguard Award — AAI recognizes immunologists at every career stage who have made exceptional scientific, institutional, or public-policy contributions. Nominations originate from the AAI Council and designated committees. The program celebrates careers defined by scientific excellence, service to the immunology community, and contributions to public advocacy, minority recruitment in the sciences, and disease research. Deadline is September 10, 2025.